Twenty-nine plans are Morningstar Medalists, and two receive Negative ratings.
It's a heterogeneous group, and the strategies appear less sensitive to rising interest rates than expected.
Gold-rated Third Avenue Real Estate Value treads lightly in REITs and, therefore, has less interest-rate sensitivity than its peers.
Although both funds represent GMO's asset-allocation views well and earn Silver ratings, GMO Benchmark-Free is a pure play on the firm's views, while GMO Global Asset Allocation is more benchmark-conscious.
Morningstar finds federal tax savings give 529s an edge.
Morningstar highlights what moves a 529 plan from good to great.
A long-tenured management team, consistent strategy, strong performance, and, now, more competitive fees bolster the case for JHancock Disciplined Value.
Despite a rocky 2014, Ivy Science & Technology remains a compelling choice for investors looking for exposure to innovative companies, both in and out of the tech sector.
Morningstar's Allocation Fund Manager of the Year stands out with its attention to investor behavior, greater diversification, and tactical tilts.
A dynamic market in 2014 gave allocation managers plenty of opportunities to stumble or soar.
Third Avenue Small Cap Value is Under Review because of impending manager changes.
MainStay ICAP International recently experienced some management changes, but it's still a solid choice for overseas exposure at a reasonable price.
Morningstar has put AllianceBernstein Discovery Value, previously rated Neutral, Under Review.
With Wadhwaney retiring, comanager Matthew Fine will assume responsibilities as Third Avenue International Value's sole lead manager.